Alloplastic skin substitute (SUPRATHEL®) dressings in treatment of donor sites in children with burns

Aim of research: 
	The aim of this study was to investigate the efficiency of alloplastic skin substitute dressings on pain syndrome and epitheliazation of donor sites in burned children.

Materials and Methods:
	Twenty-four patients with 2-3 degree burns up 3% to 15% of body surface were studied. Patients were treated in Burn Center from 1 January to 31 December 2016. Split grafts were isolated with disc dermatome. Thickness of grafts was 0.3-0.4 mm. SUPRATHEL® was placed on donor wounds in 11 patients. In control group (13 patients) one-level gauze ointment dressings were used. Patients age in SUPRATELR and control group did not differ (11.9±3.36 and 14.2±4.94 months, Z=-1.2, p=0.23).

Results: 
In SUPRATHEL® group the dressings were not removed until complete epitheliazation of donor wounds and changing of SUPRATHEL® dressings was not necessary. In control group changing of dressings was needed in 4 patients.
	The Study has proved that in case of use of alloplastic skin substitute SUPRATHEL®, median epitheliazation time was 5.7±1.01 days, in control group - time was 8.7±1.49 days (Z=-3.8, p=0.0002). According to Verbal Descriptor Scale expression of pain syndrome was less in SUPRATHEL®  group than in control group (1.5±1.04 and 5.2±0.9 respectively, Z=-4.1, P<0.001).

Conclusion: 
	Our study shown that use of alloplastic skin substitute SUPRATHEL® is effective in treatment of donor wounds in pediatric burns. Time of epithelization is shortened and pain syndrome is reduced.

Alloplastic skin substitute* dressings in treatment of donor sites in children with burns